IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Congenital CMV and Hearing Loss in Children up to 4 Years of Age: Treating With Valganciclovir Therapy
This study is currently recruiting participants.
Verified May 2017 by David Kimberlin, MD, University of Alabama at Birmingham
Sponsor:
University of Alabama at Birmingham
Information provided by (Responsible Party):
David Kimberlin, MD, University of Alabama at Birmingham
ClinicalTrials.gov Identifier:
NCT01649869
First received: July 20, 2012
Last updated: May 23, 2017
Last verified: May 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | September 2019 |
| Estimated Primary Completion Date: | September 2019 (Final data collection date for primary outcome measure) |